Ferritin Quantitative Test

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay)

C-peptide Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-peptide concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.

Product Detail

Application

C-peptide is a substance produced by the pancreas, along with insulin. Insulin is a hormone that controls the body's glucose (blood sugar) levels. Glucose is the primary source of energy for the body. If the body does not produce the appropriate amount of insulin, it may be an indication of diabetes.

 

C-peptide and insulin are released from the pancreas simultaneously and in approximately equal amounts. As a result, a C-peptide test can provide insights into the body's insulin production levels. This test can be a useful way to measure insulin levels because C-peptide tends to remain in the body for a longer duration compared to insulin.

 

The key advantage of using a C-peptide test is that it can offer a more accurate assessment of the body's insulin production capacity. Insulin itself is cleared from the bloodstream relatively quickly, making it more challenging to measure. In contrast, C-peptide has a longer half-life, providing a more reliable indicator of the pancreas's insulin-producing capabilities.

 

By analyzing C-peptide levels, healthcare providers can gain valuable information about the underlying cause of a patient's diabetes, which can inform the most appropriate treatment approach. This test can be particularly useful in differentiating between type 1 and type 2 diabetes, as well as in monitoring the progression of the disease and the effectiveness of insulin therapy.

 

In summary, the C-peptide test provides a valuable tool for healthcare professionals to assess and manage diabetes by offering insights into the body's insulin production and secretion dynamics.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.1- 40.00 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Assessment of Endogenous Insulin Production

Distinguishing Type 1 and Type 2 Diabetes

Monitoring Islet Cell Transplants

Assessment of Insulinoma

Evaluation of Hypoglycemia

 

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay)
INS Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Insulin (INS) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of diabetes diseases.
Biotime Myo Rapid Quantitative Test
Myo Rapid Quantitative Test
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
biotime CEA Rapid Quantitative Test
CEA Rapid Quantitative Test
Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
CRP Rapid Quantitative Test (Chemiluminescence Immunoassay)
CRP Rapid Quantitative Test (Chemiluminescence Immunoassay)
CRP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the C-reactive proteins (CRP) concentration in human serum, plasma and vein whole blood specimens.
Biotime Total IgE Rapid Quantitative Test
Total IgE Rapid Quantitative Test
Immunoglobulin E (IgE) is a type of antibody (or immunoglobulin (Ig)"isotype") that has only been found in mammals. IgE is synthesised by plasma cells. IgE's main function is immunity to parasites such as helminths like Schistosoma mansoni, Trichinella spiralis, and Fasciola hepatica. Total IgE is utilized during immune defense against certain protozoan parasites such as Plasmodium falciparum. Total IgE may have evolved as a last line of defense to protect against venoms.
Biotime CKMB Rapid Quantitative Test
CK-MB Rapid Quantitative Test
CK-MB is very valuable for the early diagnosis of AMI. The Biotime CK-MB test kit can perform the test accurately and rapidly within 15 minutes with Biotime Analyzers.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact